发明名称 CD44 LIGAND
摘要 PROBLEM TO BE SOLVED: To obtain a new ligand, a glycoprotein having specific molecular weight with the sugar chain representing chondroitintetrasulfuric acid, having serine-glycine recurring unit, capable of activating cytotoxic T-cells via CD44, and useful for the research and prevention of cancer. SOLUTION: This new ligand is for protein CD44 lying on cell surface and has an important role concerning metastasis or lymphocyte homing and useful as e.g. a reagent for chancer research or a cancer preventive, having the following characteristics: a glycoprotein (proteoglycan) about 600,000 in molecular weight; the molecular weight of the protein portion (chore protein) is about 18,000-22,000; the sugar chain represents chondroitintetrasulfuric acid; the amino acid sequence of the protein contains serine-glycine recurring units; capable of activating cytotoxic T-cells via CD44 borne by the T-cells; and capable of binding to the CD44 on a site differing from the binding site for the CD44 and hyaluronic acid. This new glycoprotein is obtained by purifying the supernatant resulted from culturing serglycine-productive cells through an anion exchange resin, gel filtration and a hydroxyapatite column.
申请公布号 JPH0925299(A) 申请公布日期 1997.01.28
申请号 JP19950200479 申请日期 1995.07.13
申请人 SUMITOMO ELECTRIC IND LTD 发明人 TANMACHI NORIKO;MIYASAKA MASAYUKI
分类号 G01N33/566;C07K14/78;C07K16/00;C07K16/28;C07K19/00;C12P21/02;C12R1/91;(IPC1-7):C07K14/78 主分类号 G01N33/566
代理机构 代理人
主权项
地址